Shanghai ZJ Bio-Tech Co. Ltd. A (688317) — Cash Flow-to-Debt Ratio
Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥6.85 Million could theoretically repay 0% of its total liabilities (CN¥327.17 Million) in one year. See free cash flow generation of Shanghai ZJ Bio-Tech Co. Ltd. A to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai ZJ Bio-Tech Co. Ltd. A Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Shanghai ZJ Bio-Tech Co. Ltd. A across 13 annual periods. Also explore Shanghai ZJ Bio-Tech Co. Ltd. A annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai ZJ Bio-Tech Co. Ltd. A (2013–2025)
Year-by-year debt coverage analysis for Shanghai ZJ Bio-Tech Co. Ltd. A. For market capitalisation and broader financial context, see 688317 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥66.85 Million | CN¥414.95 Million | ▼ -68.2% |
| 2024 | 0.51x | CN¥77.59 Million | CN¥153.06 Million | ▲ +254.3% |
| 2023 | -0.33x | CN¥-81.88 Million | CN¥249.25 Million | ▼ -130.5% |
| 2022 | 1.08x | CN¥584.97 Million | CN¥543.44 Million | ▼ -28.4% |
| 2021 | 1.50x | CN¥641.94 Million | CN¥427.27 Million | ▼ -45.1% |
| 2020 | 2.74x | CN¥1.14 Billion | CN¥416.97 Million | ▲ +150.3% |
| 2019 | 1.09x | CN¥76.66 Million | CN¥70.09 Million | ▼ -36.3% |
| 2018 | 1.72x | CN¥80.63 Million | CN¥46.98 Million | ▲ +55.3% |
| 2017 | 1.11x | CN¥48.00 Million | CN¥43.42 Million | ▲ +5.9% |
| 2016 | 1.04x | CN¥44.53 Million | CN¥42.66 Million | ▲ +315.2% |
| 2015 | 0.25x | CN¥12.78 Million | CN¥50.82 Million | ▼ -18.6% |
| 2014 | 0.31x | CN¥27.57 Million | CN¥89.28 Million | ▼ -43.3% |
| 2013 | 0.54x | CN¥28.16 Million | CN¥51.75 Million | — |